Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M; ELEVATE Study Group. de Fijter JW, et al. Among authors: toselli l. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14. Am J Transplant. 2017. PMID: 28027625 Free article. Clinical Trial.
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.
Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, Neff GW, Ranjan D, Toselli LT, Gane EJ, Scarola J, Alberts RG, Maller ES, Lo CM; Sirolimus Liver Conversion Trial Study Group. Abdelmalek MF, et al. Among authors: toselli lt. Am J Transplant. 2012 Mar;12(3):694-705. doi: 10.1111/j.1600-6143.2011.03919.x. Epub 2012 Jan 10. Am J Transplant. 2012. PMID: 22233522 Free article. Clinical Trial.
Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study.
Stefoni S, Midtved K, Cole E, Thervet E, Cockfield S, Buchler M, Toselli L, Pallardo LM, Schena FP, Pilmore H, Kessler M, Chadban S, Carreño CA; MO2ART Study Group. Stefoni S, et al. Among authors: toselli l. Transplantation. 2005 Mar 15;79(5):577-83. doi: 10.1097/01.tp.0000153158.91683.34. Transplantation. 2005. PMID: 15753847 Clinical Trial.
Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E. Thervet E, et al. Among authors: toselli l. Transplantation. 2003 Sep 27;76(6):903-8. doi: 10.1097/01.TP.0000089006.00653.64. Transplantation. 2003. PMID: 14508352 Clinical Trial.
Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?
McCormack L, Gadano A, Lendoire J, Quiñonez E, Imventarza O, Andriani O, Toselli L, Gil O, Gondolesi G, Bisigniano L, De Santibañes E. McCormack L, et al. Among authors: toselli l. HPB (Oxford). 2010 Oct;12(8):531-7. doi: 10.1111/j.1477-2574.2010.00200.x. HPB (Oxford). 2010. PMID: 20887320 Free PMC article.
46 results